South London and Maudsley NHS Foundation Trust   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: London United Kingdom (1999)

Organization Overview

First Clinical Trial
2010
NCT00973908
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

NHS DISCOVER Team, South London & Maudsley NHS Foundation Trust | South London and Maudsley NHS Foundation Trust | South London and the Maudsley NHS Foundation Trust

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Treatment-Resistant (Phase 4)

Diarrhea (Phase 3)

Schizophrenia (Phase 2)

Schizophrenia Spectrum and Other Psychotic Disorders (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 9
  • # of Trial APIs: 20